• English
    • suomi
  • English 
    • English
    • suomi
  • Login
View Item 
  •   Home
  • Artikkelit
  • Terveystieteiden tiedekunta
  • View Item
  •   Home
  • Artikkelit
  • Terveystieteiden tiedekunta
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Up-regulation of Mismatch Repair Pathway by Suicide Gene Therapy: Implications on the use of Temozolomide Treatment in Malignant Glioma

Thumbnail
View/Open
Article (788.0Kb)
Self archived version
published version
Date
2018
Author
Samaranayake, Haritha Dhammika
Olsson, Venla
Kurkipuro, Jere Tuomas
Määttä, Ann-Marie
Stedt, Hanna
Kärkkäinen, Hanna-Riikka
Kaikkonen, Minna U
Taavitsainen, Miia
Vuorio, Taina
Parker, Nigel
Ylä-Herttuala, Seppo
Unique identifier
10.4172/1948-5956.1000547
Metadata
Show full item record
More information
Research Database SoleCris

Self-archived article

Citation
Samaranayake, Haritha Dhammika. Olsson, Venla. Kurkipuro, Jere Tuomas. Määttä, Ann-Marie. Stedt, Hanna. Kärkkäinen, Hanna-Riikka. Kaikkonen, Minna U. Taavitsainen, Miia. Vuorio, Taina. Parker, Nigel. Ylä-Herttuala, Seppo. (2018). Up-regulation of Mismatch Repair Pathway by Suicide Gene Therapy: Implications on the use of Temozolomide Treatment in Malignant Glioma.  Journal of Cancer Science & Therapy, 10 (8) , 214-222. 10.4172/1948-5956.1000547.
Rights
© Authors
Licensed under
CC BY http://creativecommons.org/licenses/by/4.0/
Abstract

Objective: The dependency of the efficacy of temozolomide (TMZ) on cellular DNA repair activities makes it therapeutically effective in approximately half of malignant glioma (MG) patient population with a dysfunctional DNA repair system. Adenovirus-mediated Herpes simplex virus thymidine kinase and ganciclovir (AdHSV-tk/GCV) suicide gene therapy is effective in those as well as in MG patients with a functional DNA repair system. When administered together, these two therapies show evidence of synergistic cytotoxicity. However, the validity of such claims has been questioned as the exact mechanism has been unknown.
Methods: The underlying mechanism was studied in rat and human MG cell lines and in an immunocompetent, orthotopic, syngeneic rat MG model.
Results: The results, for the first time, revealed an up-regulation of mismatch repair (MMR) pathway in MG cells by AdHSV-tk/GCV therapy, an adjunct effect to AdHSV-tk/GCV’s pro-apoptotic therapeutic mode of action that enhanced the cytotoxicity of TMZ. When combined with AdHSV-tk/GCV therapy, initially resistant MG cells were sensitized to TMZ treatment. The enhancement of TMZ’s efficacy was also seen in vivo as a significant increase in survival and a reduction in tumor growth rate, without affecting the adverse effect profile.
Conclusion: This study demonstrates a synergistic outcome of AdHSV-tk/GCV and TMZ treatment combination, underlying mechanism for the synergy and a possible improved therapeutic protocol for enhanced efficacy. The findings may have an impact on future clinical use of this treatment combination, as well as benefit other chemotherapies, which depend on MMR pathway for action.

Subjects
malignant glioma   suicide gene therapy   temozolomide   mismatch repair   synergy   adenovirus   DNA repair   
URI
https://erepo.uef.fi/handle/123456789/7183
Link to the original item
http://dx.doi.org/10.4172/1948-5956.1000547
Publisher
OMICS Publishing Group
Collections
  • Terveystieteiden tiedekunta
University of Eastern Finland
OpenAccess
eRepo
erepo@uef.fi
Send Feedback
OpenUEF
Service provided by
the University of Eastern Finland Library
Library web pages
Twitter
Facebook
Youtube
Library blog
 

Browse

All of the ArchiveResource types & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects

My Account

Login
University of Eastern Finland
OpenAccess
eRepo
erepo@uef.fi
Send Feedback
OpenUEF
Service provided by
the University of Eastern Finland Library
Library web pages
Twitter
Facebook
Youtube
Library blog